SEC Filing Summary: Bioptix, Inc. (Form 8-K)
Business Context and Reporting Period
This Form 8-K Current Report, dated August 21, 2017, details the results of a Special Meeting of stockholders held by Bioptix, Inc. The filing reports on corporate governance actions, capital structure amendments, and financing authorizations approved by shareholders. Note: The input metadata references "Riot Platforms, Inc.," but the filing text explicitly identifies the registrant as Bioptix, Inc.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. The document focuses exclusively on voting results and corporate actions. Specific financial figures mentioned relate to authorized capital and financing instruments:
- Authorized Common Stock: Increased from 60,000,000 to 170,000,000 shares.
- Preferred Stock Authorization: 15,000,000 shares of "blank check" preferred stock authorized.
- Equity Incentive Plan: 895,000 shares of common stock reserved.
- Convertible Notes: Approval sought for $4.75 million in convertible promissory notes issued in a March 2017 private placement.
- Warrant Exercise: Board authorized issuance of up to $8,500,000 of common stock upon exercise of warrants at an amended price of $3.00 per share.
Material Changes
The following material changes were approved by shareholders at the Special Meeting:
- State of Incorporation: Changed from Colorado to Nevada.
- Capital Structure: Significant increase in authorized common stock and authorization of preferred stock.
- Financing Flexibility: Shareholders approved the ability to issue securities in non-public offerings at discounts of up to 30% and 20% below market price, subject to Nasdaq rules.
- Compensation: Adoption of the 2017 Equity Incentive Plan.
Guidance, Outlook, and Risks
The filing contains no management guidance, financial outlook, or discussion of future risks. The primary contingency noted is the requirement to satisfy Nasdaq Capital Market rules (specifically Rule 5635(d)) regarding the issuance of securities at discounts and the ratification of prior private placements. The filing incorporates a press release (Exhibit 99.1) issued on August 23, 2017, which is not included in the provided text.
Investor Verification Checklist
- Verify the current state of incorporation is now Nevada.
- Confirm the updated authorized share count (170,000,000 common; 15,000,000 preferred).
- Review the terms of the $4.75 million convertible notes and the $3.00 warrant exercise price to assess potential dilution.
- Check subsequent filings for details on the 2017 Equity Incentive Plan grants.
- Monitor future non-public offerings for discounts up to 30% as now authorized.